Shortage reports
Actual shortage:
257 (7%)
Anticipated shortage:
3 (0%)
Avoided shortage:
11 (0%)
Resolved:
3300 (92%)
3571
Discontinuation Reports
To be discontinued:
24 (7%)
Discontinued:
342 (93%)
Reversed:
0 (0%)
366
143 (4%)
32 (11%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-OLMESARTAN | 20MG | TABLET | Resolved | 2018-12-27 | 2020-08-10 | 70529 |
| APO-OLMESARTAN | 20MG | TABLET | Resolved | 2017-08-14 | 2018-01-19 | 19231 |
| APO-OLMESARTAN | 20MG | TABLET | Actual shortage | 2024-01-19 | 2024-05-10 | 216711 |
| APO-OLMESARTAN | 40MG | TABLET | Resolved | 2017-07-31 | 2018-01-20 | 17614 |
| APO-OLMESARTAN | 20MG | TABLET | Resolved | 2022-01-07 | 2022-02-07 | 152324 |
| APO-OLMESARTAN | 40MG | TABLET | Resolved | 2018-07-11 | 2020-09-01 | 55287 |
| APO-OLMESARTAN | 20MG | TABLET | Avoided shortage | 2018-07-15 | 2018-08-21 | 55801 |
| APO-OLMESARTAN/HCTZ | 12.5MG 20MG | TABLET | Resolved | 2018-07-04 | 2018-11-22 | 54303 |
| APO-OLMESARTAN/HCTZ | 25MG 40MG | TABLET | Actual shortage | 2024-01-19 | 2024-11-14 | 216717 |
| APO-OLMESARTAN/HCTZ | 25MG 40MG | TABLET | Resolved | 2018-01-17 | 2018-04-23 | 36321 |
| APO-OLMESARTAN/HCTZ | 25MG 40MG | TABLET | Resolved | 2018-07-04 | 2020-07-11 | 54300 |
| APO-OLMESARTAN/HCTZ | 12.5MG 20MG | TABLET | Resolved | 2018-12-27 | 2020-07-11 | 70532 |
| APO-OLMESARTAN/HCTZ | 12.5MG 40MG | TABLET | Resolved | 2018-12-12 | 2020-07-11 | 69452 |
| APO-OLMESARTAN/HCTZ | 25MG 40MG | TABLET | Resolved | 2017-07-25 | 2017-11-17 | 16895 |
| APO-OLMESARTAN/HCTZ | 12.5MG 40MG | TABLET | Actual shortage | 2024-01-19 | 2024-11-14 | 216723 |
| APO-OLMESARTAN/HCTZ | 12.5MG 20MG | TABLET | Actual shortage | 2024-01-19 | 2024-09-16 | 216720 |
| APO-OLMESARTAN/HCTZ | 12.5MG 20MG | TABLET | Resolved | 2017-07-25 | 2018-04-23 | 16900 |
| APO-OLMESARTAN/HCTZ | 12.5MG 40MG | TABLET | Resolved | 2017-07-25 | 2018-04-23 | 16905 |
| APO-OLOPATADINE | 0.2% | SOLUTION | Resolved | 2017-05-30 | 2017-06-30 | 11567 |
| APO-OLOPATADINE | 0.2% | SOLUTION | Resolved | 2019-11-20 | 2021-09-01 | 99317 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-LAMIVUDINE | 300MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60560 |
| APO-LAMIVUDINE HBV | 100MG | TABLET | Discontinued | 2018-09-07 | 2019-12-21 | 60563 |
| APO-LATANOPROST-TIMOP | Discontinued | 2018-09-07 | 2018-09-15 | 60572 | ||
| APO-LEVOCARB - TAB 25MG/250MG | 25MG 250MG | TABLET | Discontinued | 2018-09-07 | 2019-02-07 | 60576 |
| APO-LISINOPRIL TABLET 10 MG | 10MG | TABLET | Discontinued | 2018-09-07 | 2019-02-02 | 60579 |
| APO-LISINOPRIL TABLET 20 MG | 20MG | TABLET | Discontinued | 2018-09-07 | 2018-11-26 | 60582 |
| APO-LISINOPRIL TABLET 5 MG | 5MG | TABLET | Discontinued | 2018-09-07 | 2019-02-13 | 60585 |
| APO-LISINOPRIL/HCTZ | 25MG 20MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1096 |
| APO-LISINOPRIL/HCTZ | 12.5MG 10MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1093 |
| APO-LISINOPRIL/HCTZ | 12.5MG 20MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1090 |
| APO-LITHIUM CARBONATE | 300MG | CAPSULE | Discontinued | 2018-09-07 | 2018-09-15 | 60588 |
| APO-LOPERAMIDE - TAB 2MG | 2MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4930 |
| APO-LORAZEPAM TAB 0.5MG | 0.5MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60591 |
| APO-LORAZEPAM TAB 1MG | 1MG | TABLET | Discontinued | 2018-09-07 | 2018-10-05 | 60594 |
| APO-LOSARTAN | 25MG | TABLET | Discontinued | 2019-02-01 | 2019-02-02 | 74376 |
| APO-LOSARTAN | 50MG | TABLET | Discontinued | 2018-09-10 | 2018-09-15 | 60987 |
| APO-LOSARTAN | 100MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71213 |
| APO-LOSARTAN/HCTZ | 12.5MG 100MG | TABLET | Discontinued | 2018-09-07 | 2018-11-02 | 60597 |
| APO-LOSARTAN/HCTZ | 25MG 100MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60600 |
| APO-LOSARTAN/HCTZ | 25MG 100MG | TABLET | Discontinued | 2018-09-10 | 2018-12-28 | 60997 |